Roche and Biocorp Launch Mallya Smart Insulin Pen for Patients with Diabetes in France

 Roche and Biocorp Launch Mallya Smart Insulin Pen for Patients with Diabetes in France

Shots:

  • The companies launched the Mallya smart insulin pen device in France to support patients with diabetes. The smart insulin pen is available in pharmacies and is compatible with any disposable insulin pens
  • The device collects and transfers insulin data with 100% accuracy and is rechargeable via its USB port. Mallya automatically collects insulin data (dose, date, time) and transfers it to Roche’s Gluci-Chek application and offers patients with diabetes better compliance with their treatment
  • The smart device focuses to simplify the daily life of patients with diabetes undergoing insulin therapy and could help to avoid errors or oversights

Click here to­ read full press release/ article | Ref: BusinessWire | Image: Forbes

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post